Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × HER2-positive Breast Cancer × Protons × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Prostatic Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, T-Cell, Peripheral 1 Lung Neoplasms 1 Locally Advanced Non-Small Cell Lung Cancer 1 Liver Neoplasms 1 HER2-positive Breast Cancer 1 Glioma 1 Glioblastoma 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1

Interventions

pertuzumab 2 Trastuzumab 2 Docetaxel 2 tucatinib 1 Protons 1 Paclitaxel 1 Fulvestrant 1 Enfuvirtide 1 Doxorubicin 1 Cyclophosphamide 1 Ado-Trastuzumab Emtansine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02345772 2018-02-20

Neohttp

Western Regional Medical Center

Phase 1/2 Terminated

4 enrolled 1 chart

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡